Originally Posted by jackD

This is their

CONCLUSION

"After six decades of autoimmune and EAE-based research, the time has come for a change in direction. For basic scientists, the challenge is to develop a new animal model of MS that replicates both demyelination and neurodegeneration. Solvent-induced demyelination might be such a model, in view of the association between solvent exposure and MS risk.25,26 For clinicians the task is to evaluate existing neuroprotective treatments. Possible candidate agents for randomized trials in early MS are antioxidants such as coenzyme Q10,27 omega-3-essential fatty acids,28 minocyclin,29 and cannabinoids,30 alone or in combination."

HA! HA! HA!

I can say no more and a lot less.

jackD